More articles on this subject
Previous
PNH: Prospect of EU approval: Patients with paroxysmal nocturnal hemoglobinuria (PNH) - a rare disease - can hope for new treatment options. For example ...
medical-tribune.de/medizin-und-forschung/artikel/iptacopan-adressiert-alternativen-signalweg-des-komplementsystemsnbsp
A Rare Day in Community Hematology Clinic: Interesting Cases in Classical Hematology
medscape.org/viewarticle/999426
Fact or Fiction: Paroxysmal Nocturnal Hemoglobinuria: Test your knowledge with this quiz.
ms.spr.ly/6184imJaQ
New treatment option for paroxysmal nocturnal hemoglobinuria: Paris - The oral complement inhibitor iptacopan improves both...
aerzteblatt.de/nachrichten/150074/Neue-Therapieoption-bei-paroxysmaler-naechtlicher-Haemoglobinurie
Fact or Fiction: Paroxysmal Nocturnal Hemoglobinuria: Can you separate fact from fiction when it comes to PNH? Test your knowledge with this quiz.
reference.medscape.com/viewarticle/999299
Paid articlePaid
Danicopan: New active ingredient complements the treatment of paroxysmal nocturnal hemoglobinuria
aerzteblatt.de/nachrichten/149549/Danicopan-Neuer-Wirkstoff-ergaenzt-Behandlung-der-paroxysmalen-naechtlichen-Haemoglobinurie
Paroxysmal Nocturnal Hemoglobinuria: 5 Things to Know: Paroxysmal nocturnal hemoglobinuria is a rare and serious blood disorder. These five things to know will ...
medscape.com/viewarticle/999425
Paroxysmal nocturnal hemoglobinuria: Iptacopan rapidly normalizes...: New Orleans - Iptacopan, an investigational complement inhibitor, restores normality in ...
aerzteblatt.de/nachrichten/139660/Paroxysmale-naechtliche-Haemoglobinurie-Iptacopan-normalisiert-rasch-die-Haemoglobinwerte
Novartis’ investigational drug shows positive outcomes in patients with rare blood disorder
financialexpress.com/healthcare/pharma-healthcare/novartis-investigational-drug-shows-positive-outcomes-in-patients-with-rare-blood-disorder/2905916/
Novartis’ investigational oral monotherapy shows positive results against rare blood disease
financialexpress.com/healthcare/pharma-healthcare/novartis-investigational-oral-monotherapy-shows-positive-results-against-rare-blood-disease/2730214/
Next
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics